SCHEMBL18643141

SCHEMBL18643141

COC(=O)c1cc(Br)ccc1OC(C)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.47
RORC P51449 1/20 0.46
NR4A2 P43354 1/20 0.45
ALDH1A1 P00352 4/20 0.41
GAA P10253 2/20 0.41
SLC6A9 P48067 6/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 1/20 0.39
GFER P55789 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
NOTUM Q6P988 1/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
LRRK2 Q5S007 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14683695 1.00 HSD17B10 (0.47) HSD17B10RORCNR4A2ALDH1A1GAA
SCHEMBL30014395 0.89 NR4A2 (0.45) HSD17B10RORCNR4A2ALDH1A1GAA
SCHEMBL8512426 0.84 HSD17B10 (0.52) HSD17B10NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL15270595 0.82 HSD17B10 (0.51) HSD17B10NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL29849022 0.82 HSD17B10 (0.51) HSD17B10NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL2825210 0.80 SLC6A9 (0.62) SLC6A9
SCHEMBL2826299 0.80 SLC6A9 (0.62) SLC6A9
SCHEMBL2823933 0.80 SLC6A9 (0.62) SLC6A9
SCHEMBL31426250 0.80 HSD17B10 (0.49) HSD17B10NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL14027054 0.80 HSD17B10 (0.49) HSD17B10NR4A2ALDH1A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2739615-B1 PHENYL-3-AZA-BICYCLO[3.1.0]HEX-3-YL-METHANONES AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM INT (DE) 2017-03-15 EP disclosed